Michel Detheux I Teos Therapeutics, Inc. (ITOS) insider trading activity
Michel Detheux is Chief Executive Officer of iTeos Therapeutics, Inc.. Currently has a direct ownership of 0 shares of ITOS, which is worth approximately $0. The most recent transaction as insider was on Nov 23, 2021, when has been sold 14,500 shares (Common Stock) at a price of $36.08 per share, resulting in proceeds of $523,160. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
100.0%
3M change
100.0%
12M change
Total Value Held
$0
Michel Detheux Transaction History
Also insider at
MD
Michel Detheux
Chief Executive Officer
Watertown, MA